FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280925870> ?p ?o ?g. }

• W2280925870 endingPage "5518" @default.
• W2280925870 startingPage "5518" @default.
• W2280925870 abstract "5518 Background: There is currently no consensus regarding the management of advanced stage uterine MMT. In an effort to better define postoperative treatment modalities and their associated outcomes, we retrospectively reviewed factors that influence progression and survival. Methods: A retrospective, multi-institution study of women diagnosed from 1997–2007 was performed. Post-operative treatment included either observation (OBS), RT (brachytherapy, whole pelvic, or combination), chemotherapy (CT) alone or with RT (CT+RT). The majority of chemotherapy regimens included carboplatinum/paclitaxel, Ifosfamide/cisplatin, cisplatin/adriamycin, Data collected included time to recurrence, overall survival and sites of recurrence. Statistics included t-test, ANOVA and Kaplan Meier. Results: 119 patients were identified with late stage uterine MMT. 81 had stage III disease and 38 had stage IV disease. The median age at diagnosis was 67 years (range: 30–86). 70 (59%) were Caucasian and 48 (40%) were African-American. 116 (87%) were optimally debulked and their survival further analyzed. 18 (15%) were observed and 9 of these patients recurred. This group had the poorest median progression free survival (PFS) of 3.4 months. The majority (N = 50, 49%) of late stage patients underwent adjuvant CT with a median PFS of 13.3 months and median OS of 15.6 months. Of these patients 33 (66%) recurred. 18 (17 %) patients underwent RT alone with a median PFS of 12.4 months and OS of 14.9 months. 14 (78%) of these patients recurred. 20 patients (19%) underwent a combination of CT and RT and 11 (55%) experienced recurrences . The combination therapy group had the longest median PFS of 14.3 months and OS of 17.2 months (p = 0.27). Conclusions: Chemotherapy had become the standard therapy for advanced stage MMT however the addition of radiation has not been established. Patients diagnosed with advanced stage MMT can achieve long-term DFS in a minority of patients (33%) treated with chemotherapy. We showed that the addition of radiation to adjuvant chemotherapy showed a slight improvement over chemotherapy alone yet the optimal therapy has yet to be defined. This retrospective review highlights the need for prospective trials of new therapeutic agents and treatment regimens for women with advanced stage uterine MMT. No significant financial relationships to disclose." @default.
• W2280925870 created "2016-06-24" @default.
• W2280925870 creator A5002992087 @default.
• W2280925870 creator A5003010016 @default.
• W2280925870 creator A5005911289 @default.
• W2280925870 creator A5021359849 @default.
• W2280925870 creator A5029352045 @default.
• W2280925870 creator A5042305442 @default.
• W2280925870 creator A5062151371 @default.
• W2280925870 creator A5063523041 @default.
• W2280925870 creator A5066680610 @default.
• W2280925870 creator A5083799488 @default.
• W2280925870 creator A5091294358 @default.
• W2280925870 date "2009-05-20" @default.
• W2280925870 modified "2023-10-17" @default.
• W2280925870 title "Improved outcomes in advanced stage uterine carcinosarcoma (mixed mullerian tumor [MMT])" @default.
• W2280925870 doi "https://doi.org/10.1200/jco.2009.27.15_suppl.5518" @default.
• W2280925870 hasPublicationYear "2009" @default.
• W2280925870 type Work @default.
• W2280925870 sameAs 2280925870 @default.
• W2280925870 citedByCount "0" @default.
• W2280925870 crossrefType "journal-article" @default.
• W2280925870 hasAuthorship W2280925870A5002992087 @default.
• W2280925870 hasAuthorship W2280925870A5003010016 @default.
• W2280925870 hasAuthorship W2280925870A5005911289 @default.
• W2280925870 hasAuthorship W2280925870A5021359849 @default.
• W2280925870 hasAuthorship W2280925870A5029352045 @default.
• W2280925870 hasAuthorship W2280925870A5042305442 @default.
• W2280925870 hasAuthorship W2280925870A5062151371 @default.
• W2280925870 hasAuthorship W2280925870A5063523041 @default.
• W2280925870 hasAuthorship W2280925870A5066680610 @default.
• W2280925870 hasAuthorship W2280925870A5083799488 @default.
• W2280925870 hasAuthorship W2280925870A5091294358 @default.
• W2280925870 hasConcept C126322002 @default.
• W2280925870 hasConcept C141071460 @default.
• W2280925870 hasConcept C146357865 @default.
• W2280925870 hasConcept C151730666 @default.
• W2280925870 hasConcept C167135981 @default.
• W2280925870 hasConcept C2776694085 @default.
• W2280925870 hasConcept C2777506904 @default.
• W2280925870 hasConcept C2777546739 @default.
• W2280925870 hasConcept C2778239845 @default.
• W2280925870 hasConcept C2778938455 @default.
• W2280925870 hasConcept C2780739268 @default.
• W2280925870 hasConcept C71924100 @default.
• W2280925870 hasConcept C86803240 @default.
• W2280925870 hasConceptScore W2280925870C126322002 @default.
• W2280925870 hasConceptScore W2280925870C141071460 @default.
• W2280925870 hasConceptScore W2280925870C146357865 @default.
• W2280925870 hasConceptScore W2280925870C151730666 @default.
• W2280925870 hasConceptScore W2280925870C167135981 @default.
• W2280925870 hasConceptScore W2280925870C2776694085 @default.
• W2280925870 hasConceptScore W2280925870C2777506904 @default.
• W2280925870 hasConceptScore W2280925870C2777546739 @default.
• W2280925870 hasConceptScore W2280925870C2778239845 @default.
• W2280925870 hasConceptScore W2280925870C2778938455 @default.
• W2280925870 hasConceptScore W2280925870C2780739268 @default.
• W2280925870 hasConceptScore W2280925870C71924100 @default.
• W2280925870 hasConceptScore W2280925870C86803240 @default.
• W2280925870 hasIssue "15_suppl" @default.
• W2280925870 hasLocation W22809258701 @default.
• W2280925870 hasOpenAccess W2280925870 @default.
• W2280925870 hasPrimaryLocation W22809258701 @default.
• W2280925870 hasRelatedWork W2007192772 @default.
• W2280925870 hasRelatedWork W2047218284 @default.
• W2280925870 hasRelatedWork W2071841151 @default.
• W2280925870 hasRelatedWork W2249883256 @default.
• W2280925870 hasRelatedWork W2413375006 @default.
• W2280925870 hasRelatedWork W2416296151 @default.
• W2280925870 hasRelatedWork W2523147384 @default.
• W2280925870 hasRelatedWork W4232411214 @default.
• W2280925870 hasRelatedWork W4251576511 @default.
• W2280925870 hasRelatedWork W4255356906 @default.
• W2280925870 hasVolume "27" @default.
• W2280925870 isParatext "false" @default.
• W2280925870 isRetracted "false" @default.
• W2280925870 magId "2280925870" @default.
• W2280925870 workType "article" @default.